Loading stock data…
SS Innovations International In (SSII)
$3.27-0.14 (-4.11%)
Market ClosedLast close Sep 8
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SS Innovations International, Inc. in the Healthcare sector is trading at $3.27 with a market capitalization of $655M. Wall Street consensus targets $7.00 (1 analysts), implying a +114.1% move over the next 12 months. The stock is currently near its 52-week low of $3.11, remaining 26.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +114.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 25) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.10M↓ | $14.53M↑ | $12.83M↑ | $10.00M↑ | $5.12M |
| Gross Profit | $5.33M↓ | $6.38M↑ | $6.16M↑ | $5.92M↑ | $1.09M |
| Operating Income | -$3.64M↓ | -$734,997↑ | -$1.84M↓ | $97,014↑ | -$5.92M |
| Net Income | -$3.58M↓ | -$2.47M↑ | -$3.72M↓ | -$256,691↑ | -$5.68M |
Peer Comparison
JNJUNHPFE
Fundamentals
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$655.26M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.58
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-23.28%
Volume
Today's trading volume
63,728
Recent News
SS Innovations (SSII) Announces Graduation of Inaugural Cardiac Robotic Surgery Training Class by Subsidiary SSICRS
SS Innovations International, Inc. (NASDAQ:SSII) is one of the best strong buy penny stocks to invest in now. SS Innovations International, Inc. (NASDAQ:SSII) announced on July 7 that its subsidiary, the SS International Centre for Robotics Surgery (SSICRS), graduated its first class in a specialised training course specialised to offer classroom instruction and hands-learnings in […]
SS Innovations names Sarah Romano as CFO
Romano, who is joining from rival robotic surgery company Vicarious Surgical, will step into a position that has been held by a series of executives over the past year.
SS Innovations International Insiders Placed Bullish Bets Worth US$5.20m
Over the last year, a good number of insiders have significantly increased their holdings in SS Innovations...
SS Innovations International, Inc. (SSII) Gains Approvals for SSi Mantra in Key Emerging Markets
We recently compiled a list of the 12 Penny Stocks with Insider Buying in 2026. SS Innovations International, Inc. is one of the best stocks with Insider buying on this list. TheFly reported on March 30 that SSII announced that its SSi Mantra surgical robotic system obtained regulatory approvals for multiple uses in Colombia, Oman, […]
SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely
SS Innovations’ robot won approvals to perform telesurgery in Indonesia and the Philippines, while the first remote robotic mechanical thrombectomy to treat stroke was performed with XCath’s system.